Investing Profile

Simeon J. George

Photo of Simeon J. George, Partner at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
SR One Partner
26
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DMay 2025$38M
$170M
Co-investors: Michal Silverberg (Novartis Venture Fund), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Matthew Foy (SR One), Chandra Leo (Hbm Partners), Ran Nussbaum (Pontifax Venture Capital)
ADARx Pharmaceuticals
Series CAug 2023$200M
Series BJan 2023$46M
Series BSep 2021$75M
$320M
Co-investors: Carl Gordon (OrbiMed), Lorence Kim (Third Rock Ventures)
Rezo Therapeutics
Series ANov 2022$78M
$78M
Co-investors: Vineeta Agarwala (Andreessen Horowitz)
Simcha Therapeutics
Series BJan 2022$40M
$40M
Design Therapeutics
Series BJan 2021$130M
Series AMar 2020$46M
$170M
Turning Point Therapeutics
Private EquityOct 2018$80M
Series CMay 2017$45M
$130M
Co-investors: Carl Gordon (OrbiMed), Chandra Leo (Hbm Partners), Hongbo Lu (Vivo Capital)
Progyny
Series BMay 2017$10M
Series BJul 2016$15M
$25M
Principia Biopharma
Series BAug 2015$15M
Series BApr 2014$50M
Series AOct 2012$13M
$78M
Co-investors: Peter Thompson (OrbiMed), Mike Dybbs (Samsara BioCapital), Nassim Usman (Morgenthaler Ventures)